Clinical Trials Logo

Clinical Trial Summary

Combined use of a novel cardioplegic formula with MPS® (Myocardial protection system) versus Cardioplexol ® (colloid solution with Procaine, magnesium and potassium) in isolated CABG (coronary artery bypass grafting) using MiECC (Minimal extracorporeal circulation system).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Complication of Coronary Artery Bypass Graft
  • Complication of Extracorporeal Circulation

NCT number NCT03612388
Study type Observational
Source University Hospital, Basel, Switzerland
Contact
Status Completed
Phase
Start date February 28, 2010
Completion date March 13, 2019

See also
  Status Clinical Trial Phase
Completed NCT01698372 - Negative Pressure Dressing After Saphenous Vein Harvest Phase 1
Completed NCT02814084 - Prevena Incision Management N/A
Not yet recruiting NCT02554305 - The Fusion Versus The Affinity Oxygenation Systems N/A
Not yet recruiting NCT01457859 - Effectiveness of Triclosan Coated Sutures in Preventing Leg Wound Infection After Coronary Artery Bypass Surgery Phase 4
Completed NCT03609723 - Combined Use of a Novel Cardioplegic Formula With MPS ® Using the MiECC in Isolated CABG Versus OPCABG
Withdrawn NCT02035163 - Atrial Fibrillation Prevention in Post Coronary Artery Bypass Graft Surgery With Cryoablation for Ganglionic Plexi N/A
Recruiting NCT02711124 - Relationship Between Level of Hemoglonin A1c and Platelet Function in Patients Undergoing Cardiac Surgery N/A
Completed NCT01406483 - Platelet Reactivity in Patients on a Thienopyridine and Awaiting Coronary Artery Bypass Grafting N/A